文献速递妇科生殖医学

甲氨蝶呤治疗输卵管妊娠后采用序贯经阴道超声与子宫输卵管泡沫超声造影评估输卵管通畅性

Tubal patency assessment using sequential transvaginal ultrasound and hysterosalpingo-foam sonography after methotrexate treatment for tubal pregnancy.
PubMed 文献 · Reprod Biomed Online · 2021-10-29

前瞻性试验纳入2019年5月至2020年11月超声诊断并接受甲氨蝶呤治疗的疑似输卵管异位妊娠患者,序贯行经阴道二维超声和子宫输卵管泡沫超声造影评估输卵管通畅性。40例入组,6例(15%)初始超声发现患侧输卵管积水被排除,34例完成造影,10例(29.4%)发现输卵管阻塞。作者建议将序贯超声和造影纳入常规随访。

要点

  • 甲氨蝶呤治疗输卵管妊娠后,40例中6例(15%)初始超声发现患侧输卵管积水。
  • 完成子宫输卵管泡沫超声造影的34例中,10例(29.4%)发现输卵管阻塞。
  • 作者建议将序贯经阴道超声和子宫输卵管泡沫超声造影纳入常规随访。

核心结论

  • 接受甲氨蝶呤治疗的输卵管妊娠女性中,40%被诊断输卵管阻塞。
  • 作者建议序贯经阴道超声和子宫输卵管泡沫超声造影成为这些女性的常规随访组成部分,以便及时转诊至相应专科。

研究设计与样本

  • 前瞻性试验,于2019年5月至2020年11月开展。
  • 纳入超声诊断的疑似输卵管异位妊娠并接受甲氨蝶呤治疗的患者。
  • 患者序贯接受经阴道二维超声评估盆腔器官及补充性子宫输卵管泡沫超声造影评估输卵管通畅性。
  • 主要结局为患侧输卵管阻塞。
  • 共360例女性接受序贯经阴道二维超声和子宫输卵管泡沫超声造影,其中40例(11.1%)符合纳入标准并入组。

主要发现

  • 40例中6例(15%)初始经阴道超声发现患侧输卵管积水,被排除进一步检查。
  • 剩余34例(85%)完成子宫输卵管泡沫超声造影,其中10例(29.4%)发现输卵管阻塞。
  • 10例阻塞中,8例(23.5%)为患侧输卵管近端阻塞,2例(5.9%)为双侧近端阻塞。
  • 子宫输卵管造影在所有受累病例中确认输卵管阻塞。
  • 未记录到操作相关并发症。

临床怎么用

  • 作者建议序贯经阴道超声和子宫输卵管泡沫超声造影成为甲氨蝶呤治疗输卵管妊娠女性的常规随访组成部分,以便及时转诊至相应专科。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the efficacy of sequential two-dimensional transvaginal ultrasound (2D-US) and hysterosalpingo-foam sonography (HyFoSy) after methotrexate (MTX) treatment for tubal pregnancy among patients who desire a future pregnancy? DESIGN: A prospective trial conducted between May 2019 and November 2020. Patients who had a suspected tubal ectopic pregnancy diagnosed by ultrasound and treated by MTX were included. These patients underwent sequential transvaginal 2D-US assessment of the pelvic organs and a complementary HyFoSy for tubal patency. The primary outcome was tubal obstruction in the affected side. RESULTS: A total of 360 women underwent sequential transvaginal 2D-US assessment of the pelvic organs and a complementary HyFoSy for tubal patency. Of these, 40 (11.1%) women fulfilling the inclusion criteria were enrolled. In six out of 40 (15%), hydrosalpinx of the affected tube was found during the initial transvaginal ultrasound examination and were excluded from further investigation. In the remaining 34 (85%) patients, HyFoSy was carried out. Tubal block was found in 10 out of 34 (29.4%) patients. Of these, eight out of 34 (23.5%) and two out of 34 (5.9%) had a proximal block of the affected tube and bilateral proximal obstruction, respectively. Hysterosalpingography confirmed the tubal obstruction in all the affected cases. No procedure-related complications were documented. CONCLUSIONS: Forty per cent of women who were treated by MTX for tubal pregnancy were diagnosed with tubal obstruction. We recommend that sequential transvaginal ultrasound and HyFoSy become part of routine follow-up for these women, thus offering them timely referral to the appropriate specialist.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Melcer Y, Gat I, Dvash S, et al. Tubal patency assessment using sequential transvaginal ultrasound and hysterosalpingo-foam sonography after methotrexate treatment for tubal pregnancy. Reprod Biomed Online. 2021. PMID: 34906423. doi:10.1016/j.rbmo.2021.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。